Gender differences in depression: findings from the STAR*D study.

Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am J Epidemiol (2008) 1.63

Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry (2010) 1.60

Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol (2006) 1.40

The epidemiology of depression in metropolitan China. Psychol Med (2008) 1.22

Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr Psychiatry (2008) 1.20

Sex differences in animal models of psychiatric disorders. Br J Pharmacol (2014) 1.15

Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci (2008) 1.12

Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. J Psychiatr Res (2006) 1.11

Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. PLoS One (2011) 1.04

Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biol Psychol (2013) 1.03

Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res (2008) 1.03

Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study. PLoS One (2012) 1.01

Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior. Transl Psychiatry (2012) 0.96

Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J Psychiatry Neurosci (2010) 0.96

The clinical research center for depression study: baseline characteristics of a korean long-term hospital-based observational collaborative prospective cohort study. Psychiatry Investig (2010) 0.94

Stress induced obesity: lessons from rodent models of stress. Front Neurosci (2013) 0.93

Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease. Neural Plast (2012) 0.91

Patient health Questionnaire-9 in spinal cord injury: an examination of factor structure as related to gender. J Spinal Cord Med (2009) 0.91

Sexual dimorphism in locus coeruleus dendritic morphology: a structural basis for sex differences in emotional arousal. Physiol Behav (2011) 0.89

β-endorphin modulates the effect of stress on novelty-suppressed feeding. Front Behav Neurosci (2013) 0.88

Can discrete event simulation be of use in modelling major depression? Cost Eff Resour Alloc (2006) 0.87

Subtypes of major depression in substance dependence. Addiction (2009) 0.87

Prevalence and characteristics of depressive disorders in early adolescents in central Norway. Child Adolesc Psychiatry Ment Health (2011) 0.87

The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition. Qual Life Res (2012) 0.87

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. J Womens Health (Larchmt) (2013) 0.84

Sex differences of gray matter morphology in cortico-limbic-striatal neural system in major depressive disorder. J Psychiatr Res (2013) 0.84

Validation of the Arab Youth Mental Health scale as a screening tool for depression/anxiety in Lebanese children. Child Adolesc Psychiatry Ment Health (2011) 0.84

Exploration of the influence of childhood trauma, combat exposure, and the resilience construct on depression and suicidal ideation among U.S. Iraq/Afghanistan era military personnel and veterans. Arch Suicide Res (2013) 0.83

Alcohol use in the first three years of bereavement: a national representative survey. Subst Abuse Treat Prev Policy (2012) 0.83

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict (2011) 0.82

Ovarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites. Exp Neurol (2011) 0.82

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? Neurosci Biobehav Rev (2012) 0.81

The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause (2010) 0.81

A proposed model for economic evaluations of major depressive disorder. Eur J Health Econ (2011) 0.81

Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2). Patient (2015) 0.81

Dietary glycaemic load and odds of depression in a group of institutionalized elderly people without antidepressant treatment. Eur J Nutr (2012) 0.80

Quality of life in mentally ill, physically ill and healthy individuals: the validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire. Ann Gen Psychiatry (2009) 0.80

Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis. Menopause (2012) 0.80

A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. J Clin Psychiatry (2013) 0.79

Exposure to early adversity: Points of cross-species translation that can lead to improved understanding of depression. Dev Psychopathol (2015) 0.79

Effects of Adolescent Universal Substance Misuse Preventive Interventions on Young Adult Depression Symptoms: Mediational Modeling. J Abnorm Child Psychol (2016) 0.79

Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons. Neuroscience (2011) 0.79

The interplay of gender, mood, and stress hormones in the association between emotional eating and dietary behavior. J Nutr (2014) 0.78

Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study. Prim Care Companion J Clin Psychiatry (2007) 0.78

PROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic Conditions. J Clin Epidemiol (2016) 0.77

The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression. Psychiatry Res (2013) 0.77

Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later. Soc Cogn Affect Neurosci (2016) 0.77

Fibromyalgia among major depression disorder females compared to males. Rheumatol Int (2008) 0.75

Suicide risk among male substance users in residential treatment: Evaluation of the depression-distress amplification model. Psychiatry Res (2016) 0.75

Sex Differences in the Relationship between Depressive Symptoms and Actigraphic Assessments of Sleep and Rest-Activity Rhythms in a Population-Based Sample. Psychosom Med (2016) 0.75

Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats. Psychopharmacology (Berl) (2014) 0.75

Amygdala Atrophy and Its Functional Disconnection with the Cortico-Striatal-Pallidal-Thalamic Circuit in Major Depressive Disorder in Females. PLoS One (2017) 0.75

β-endorphin regulates alcohol consumption induced by exercise restriction in female mice. Alcohol (2016) 0.75

Gender Differences in Depressive Symptom Profile: Results from Nationwide General Population Surveys in Korea. J Korean Med Sci (2015) 0.75

Maternal immune activation epigenetically regulates hippocampal serotonin transporter levels. Neurobiol Stress (2016) 0.75

The effects of the gender-culture interaction on self-reports of depressive symptoms: cross-cultural study among Egyptians and Canadians. PeerJ (2016) 0.75

Minimal depression: how does it relate to upper-extremity impairment and function in stroke? Am J Occup Ther (2013) 0.75

N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment. Depress Res Treat (2010) 0.75

RasGRF1 regulates the hypothalamic-pituitary-adrenal axis specifically in early-adolescent female mice. J Endocrinol (2015) 0.75

Gender Differences in the Clinical Characteristics of Psychotic Depression: Results from the CRESCEND Study. Clin Psychopharmacol Neurosci (2015) 0.75

Neonatal overfeeding disrupts pituitary ghrelin signalling in female rats long-term; Implications for the stress response. PLoS One (2017) 0.75

Community Partners in Care: 6-Month Outcomes of Two Quality Improvement Depression Care Interventions in Male Participants. Ethn Dis (2017) 0.75

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83

A draft sequence of the rice genome (Oryza sativa L. ssp. japonica). Science (2002) 21.26

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41

Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07

Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial. Ann Intern Med (2015) 6.66

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64

Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA (2006) 6.26

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00

Medication augmentation after the failure of SSRIs for depression. N Engl J Med (2006) 5.16

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05

Exercise treatment for depression: efficacy and dose response. Am J Prev Med (2005) 4.99

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98

Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol (2013) 4.20

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90

Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol (2008) 3.65

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60

Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2004) 3.43

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry (2008) 3.40

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34

Estimating Individualized Treatment Rules Using Outcome Weighted Learning. J Am Stat Assoc (2012) 3.13

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry (2006) 2.90

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry (2007) 2.87

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84

Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55

Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry (2005) 2.50

STAR*D: what have we learned? Am J Psychiatry (2007) 2.47

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43

Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry (2008) 2.42

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry (2006) 2.21

Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med (2002) 2.21

Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol (2004) 2.21

Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA (2010) 2.16

Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry (2005) 2.13

Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry (2004) 2.11

The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep (2007) 2.08

Symptoms of depressed mood, disturbed sleep, and sexual problems in midlife women: cross-sectional data from the Study of Women's Health Across the Nation. J Womens Health (Larchmt) (2015) 2.05

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2004) 2.04

Evidence-based recommendations for the prescription of exercise for major depressive disorder. J Psychiatr Pract (2013) 2.04

Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav (2009) 2.03

Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res (2013) 1.99

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol (2011) 1.98

Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry (2002) 1.93

Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders. Neuropsychopharmacology (2006) 1.93

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry (2008) 1.92

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry (2006) 1.90

Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry (2003) 1.89

Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract (2006) 1.89

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry (2007) 1.88

Reduction in the incidence of influenza A but not influenza B associated with use of hand sanitizer and cough hygiene in schools: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.87

Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry (2004) 1.86

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry (2008) 1.86

Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry (2010) 1.85

The pattern of sensory processing abnormalities in autism. Autism (2006) 1.83